Bio-Techne (TECH) Gross Margin (2009 - 2026)
Bio-Techne (TECH) posted quarterly Gross Margin of 66.88% for Q1 2026, down 97.0% year-over-year from 2229.48% in Q1 2025, and up 3.46% quarter-over-quarter from 64.65% in Q4 2025.
Analysis
Bio-Techne (TECH) Gross Margin (2009 - 2026) Analysis & Trends
Bio-Techne's Gross Margin history runs 18 years deep, the most recent figure standing at 66.88% for Q1 2026.
- In Q1 2026, Gross Margin fell 97.0% year-over-year to 66.88%; the TTM figure through Mar 2026 stood at 64.96% (down 80.0% YoY), while the FY2025 annual figure was 64.8%, down 161.0% from the prior year.
- Gross Margin for Q1 2026 stood at 66.88%, up from 64.65% in the prior quarter.
- The five-year high for Gross Margin was 8979.75% in Q3 2022, with the low at 62.72% in Q2 2025.
- The 5-year median for Gross Margin is 66.88% (2026), against an average of 590.86%.
- The sharpest annual moves came in 2022 and 2023: Gross Margin soared 891340 bps in 2022, then sank 891288 bps in 2023.
- Bio-Techne's Gross Margin stood at 67.52% in 2022, then declined by 4 bps to 64.78% in 2023, then rose by 1 bps to 65.27% in 2024, then declined by 1 bps to 64.65% in 2025, then gained by 3 bps to 66.88% in 2026.
- Business Quant data shows TECH's Gross Margin at 66.88% in Q1 2026, 64.65% in Q4 2025, and 65.65% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 84.20% |
| 10 | Bio-Techne | 11.30 Bn | 11.03 Bn | 211.39 Mn | 65.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.82% |
| Mar 31, 2026 | 66.88% |
| Dec 31, 2025 | 64.65% |
| Sep 30, 2025 | 65.65% |
| Jun 30, 2025 | 62.72% |
| Mar 31, 2025 | 67.86% |
| Dec 31, 2024 | 65.27% |
| Sep 30, 2024 | 63.23% |
| Jun 30, 2024 | 66.43% |
| Mar 31, 2024 | 67.43% |
| Dec 31, 2023 | 64.78% |
| Sep 30, 2023 | 66.87% |
| Jun 30, 2023 | 67.93% |
| Mar 31, 2023 | 68.73% |
| Dec 31, 2022 | 67.52% |
| Sep 30, 2022 | 66.60% |
| Jun 30, 2022 | 69.51% |
| Mar 31, 2022 | 69.38% |
| Dec 31, 2021 | 68.22% |
| Sep 30, 2021 | 66.35% |